市場調査レポート

商品コード

1633616

頭蓋内動脈瘤の市場規模、シェア、成長分析：製品タイプ別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

Intracranial Aneurysm Market Size, Share, Growth Analysis, By Product Type (Aneurysm Therapeutic Devices, Embolization Devices), By Type (Saccular aneurysm, Fusiform aneurysm), By End-User, By Region - Industry Forecast 2025-2032

出版日: 2025年01月14日
発行: SkyQuest
ページ情報: 英文 236 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 3,500 504,210円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 4,400 633,864円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 5,300 763,518円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

頭蓋内動脈瘤の世界市場規模は2023年に13億米ドルと評価され、2024年の14億2,000万米ドルから2032年には28億2,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは9.0％で成長する見通しです。

世界の頭蓋内動脈瘤市場は、高齢化、早期診断・早期介入に対する意識の高まり、医療技術の力強い進歩に後押しされ、持続的な成長が見込まれています。先進国市場と新興国市場の両方でヘルスケア支出が増加し、特に頭蓋内動脈瘤の診断と治療において、必要不可欠なサービスへのアクセスが広がっています。コイリング術や流路転換術のような低侵襲血管内治療法の台頭は、そのリスクプロファイルの低さ、入院期間の短縮、回復時間の改善により注目を集めています。さらに、画像診断技術の向上により、より正確な発見と治療計画が可能になった。しかし、治療費の高さや血管内治療の複雑さといった課題は、市場拡大の妨げになる可能性があります。認知度と技術が進歩し続ける中、これらの障壁に対処することが、市場の可能性を最大化する上で極めて重要になると思われます。

市場概要
動脈瘤治療機器
- クリップ
- コイル
- 血管内デバイス
- フローダイバータ
塞栓デバイス
- 閉塞カテーテル
- 塞栓剤
吸引装置
- 吸引カテーテル
- 血栓除去装置
アクセスデバイス
- マイクロカテーテル
- ガイドワイヤー

頭蓋内動脈瘤市場規模：タイプ別& CAGR（2025-2032）

市場概要
嚢状動脈瘤
紡錘状動脈瘤
真菌性動脈瘤

頭蓋内動脈瘤市場規模：エンドユーザー別& CAGR（2025-2032）

市場概要
病院
専門クリニック
その他

頭蓋内動脈瘤市場規模：地域別& CAGR（2025-2032）

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Medtronic plc（Ireland）
Stryker Corporation（United States）
MicroPort Scientific Corporation（China）
Johnson & Johnson Services, Inc.（United States）
MicroVention Inc.（United States）
B. Braun Melsungen AG（Germany）
Integra LifeSciences（United States）
RAUMEDIC AG（Germany）
Terumo Corporation（Japan）
Delta Surgical（United Kingdom）
MicroVention Terumo（United States）
Penumbra, Inc.（United States）
Balt USA（United States）
Phenox GmbH（Germany）
InspireMD, Inc.（Israel）
Kaneka Medix Corporation（Japan）
Evasc Neurovascular Enterprises ULC（Canada）

結論と推奨事項

Product Code: SQMIG35A2427

Global Intracranial Aneurysm Market size was valued at USD 1.3 billion in 2023 and is poised to grow from USD 1.42 billion in 2024 to USD 2.82 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The global intracranial aneurysm market is poised for sustained growth, fueled by an aging population, heightened awareness around early diagnosis and intervention, and robust advancements in medical technology. Increased healthcare spending in both developed and emerging markets has broadened access to essential services, particularly in diagnosing and treating intracranial aneurysms. The rise of minimally invasive endovascular techniques, like coiling and flow diversion, has garnered attention due to their lower risk profiles, reduced hospital stays, and improved recovery times. Additionally, enhanced imaging technologies have enabled more accurate detection and treatment planning. However, challenges such as high treatment costs and the complexities of endovascular procedures may hinder market expansion. As awareness and technology continue to advance, addressing these barriers will be crucial for maximizing market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intracranial Aneurysm market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intracranial Aneurysm Market Segmental Analysis

Global Intracranial Aneurysm Market is segmented by Product Type, Type, End-User and region. Based on Product Type, the market is segmented into Aneurysm Therapeutic Devices, Embolization Devices, Aspiration Devices and Access Devices. Based on Type, the market is segmented into Saccular aneurysm, Fusiform aneurysm and Mycotic aneurysm. Based on End-User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intracranial Aneurysm Market

The global market for intracranial aneurysms is primarily driven by significant technological advancements in the medical field. Innovations such as minimally invasive endovascular procedures, enhanced imaging techniques, and the introduction of cutting-edge devices are pivotal in fostering market expansion. These developments not only improve treatment efficacy but also contribute to enhanced patient experiences by minimizing discomfort and expediting recovery periods. As healthcare professionals adopt these advanced technologies, the overall quality of care for patients with intracranial aneurysms is expected to improve, further propelling growth in this market segment.

Restraints in the Global Intracranial Aneurysm Market

The global market for intracranial aneurysms faces significant constraints due to exorbitant treatment costs. Patients requiring intervention for these conditions often encounter substantial expenses, particularly in cases that involve complex procedures or advanced medical devices. This financial burden can create barriers to accessing necessary care for some individuals and potentially lead to disparities in treatment options. Additionally, the high costs can place considerable strain on healthcare systems, affecting their ability to provide comprehensive care for all patients suffering from intracranial aneurysms. Ultimately, these economic factors can hinder overall market growth and patient outcomes in this critical area of healthcare.

Market Trends of the Global Intracranial Aneurysm Market

The Global Intracranial Aneurysm market is witnessing a significant shift towards minimally invasive procedures, driven by advancements in endovascular techniques such as coiling and flow diversion. These methods are increasingly favored for their lower invasiveness, shorter recovery times, and improved patient outcomes compared to traditional open surgical interventions. As healthcare providers and patients prioritize safety and efficiency, the demand for these innovative treatments continues to surge, leading to enhanced market growth. This trend not only reflects broader healthcare advancements but also underscores the imperative for ongoing research and development in neurovascular therapies, positioning the market for sustained expansion in the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Intracranial Aneurysm Market Size by Product Type & CAGR (2025-2032)

Market Overview
Aneurysm Therapeutic Devices
- Clips
- Coils
- Intravascular Devices
- Flow Diverter
Embolization Devices
- Occlusion Catheters
- Embolic Agent
Aspiration Devices
- Aspiration Catheter
- Clot Retrieval Device
Access Devices
- Micro Catheter
- Guidewire

Global Intracranial Aneurysm Market Size by Type & CAGR (2025-2032)

Market Overview
Saccular aneurysm
Fusiform aneurysm
Mycotic aneurysm

Global Intracranial Aneurysm Market Size by End-User & CAGR (2025-2032)

Market Overview
Hospitals
Specialty Clinics
Others

Global Intracranial Aneurysm Market Size & CAGR (2025-2032)

North America (Product Type, Type, End-User)
- US
- Canada
Europe (Product Type, Type, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RAUMEDIC AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Delta Surgical (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention Terumo (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balt USA (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phenox GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InspireMD, Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Medix Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evasc Neurovascular Enterprises ULC (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments